COVID-19: Phase-3 trial of COVAXIN to begin in UP's Lucknow, Gorakhpur from October
Sep 25, 2020
Lucknow (Uttar Pradesh) [India], September 25 : The Uttar Pradesh government on Thursday announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start in Lucknow and Gorakhpur from October.
"The phase-3 trial of COVAXIN being developed by Bharat Biotech will start in Lucknow and Gorakhpur from October," said Uttar Pradesh Principal Health Secretary Amit Mohan Prasad here in a press conference.
The Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech for the development of the COVAXIN.
Meanwhile, Congress leader Deepak Singh on Thursday wrote a letter to Chief Minister Yogi Adityanath and requested to increase testing for COVID-19 in Uttar Pradesh.
According to the Union Health Ministry as of Thursday, there are 61,698 active cases in the state with 3,02,689 recovered people and 5,299 deaths.
